Collegium Pharmaceutical, Inc. /
BioDelivery Sciences International, Inc.
Collegium Pharmaceutical, Inc. agrees to buy BioDelivery Sciences International, Inc.
- Price
- $607m
- Stage
- Agreement signed
What happened
Collegium Pharmaceutical, Inc. agreed to acquire BioDelivery Sciences International, Inc. for approximately $607 million, according to a filing dated March 23, 2022.
The source
Everything on this page comes from the source below.
Collegium Pharmaceutical, Inc. agrees to buy BioDelivery Sciences International, Inc.
This document is the source for the companies, stage, figure and people on this page.
Original filingUnlock with ProTimeline
Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.
Published by the source
The source this page is built from.
Announced
The source this page is built from.
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Request accessAlready invited? Sign in
Carrywatch Pro is by invitation. An invite lets you buy Pro.
By email · Weekly